Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis: a Non-inferiority Randomized Trial

NCT05642208 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT05642208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05642208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dupilumab Step-down Strategy to Maintain Remission in Adult and Adolescents Patients With Atopic Dermatitis: a Non-inferiority Randomized Trial
Lead sponsor
Nantes University Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 8, 2023
Completion date
August 27, 2026
Enrollment
256 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis, eczema, atopic